The auditor for Promisia Integrative’s 2018 financial results says it can’t tell whether the supplement company is a going concern, although the director insists it is.
The NZX-listed company was hit with two Medsafe warnings over its Arthrem product in the past year, the first of which
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
